Xu X, Zeng W, Diaz J, Lau K S, Gukovskaya A C, Brown R J, Pandol S J, Muallem S
Department of Physiology, University of Texas, Southwestern Medical Center, Dallas 75235, USA.
Cell Calcium. 1997 Sep;22(3):217-28. doi: 10.1016/s0143-4160(97)90015-4.
Regulation of agonist-activated Ca2+ influx by the NOS pathway through generation of cGMP is being found in an increasing number of cell types. In the present work, we examined the role of the NOS pathway in agonist-evoked [Ca2+]i oscillations and attempted to identify the NOS isoform most likely to regulate Ca2+ influx. For this, we first show that two Ca(2+)-mobilizing agonists acting on pancreatic acinar cells, bombesin (BS) and the cholecystokinin analog CCK-JMV-180 (CCKJ), evokes different type of [Ca2+]i oscillations. The BS-evoked [Ca2+]i oscillations rapidly became acutely dependent on the presence of extracellular Ca2+, whereas the CCKJ-evoked oscillations continue for long periods of time in the absence of Ca2+ influx. This differential behavior allowed us to isolate Ca2+ influx and study its regulation while controlling for non specific effects on all other Ca2+ transporting events involved in generating [Ca2+]i oscillations. Inhibitors of selective steps in the NOS pathway inhibited agonist-induced cGMP production. The inhibitors were then used to show that scavenging NO with reduced hemoglobin, inhibition of guanylyl cyclase with 1H-[1,2,4] oxadiazolo[4,3-a] quinoxaline-1-one (ODQ) and inhibition of protein kinase G with Rp-8-pCPT-cGMPS inhibited [Ca2+]i oscillations evoked by BS but not those evoked by CCKJ. These findings were extended to duct and acinar cells of the SMG. In these cells, Ca(2+)-mobilizing agonists stimulate large Ca2+ influx, which was inhibited by all inhibitors of the NOS pathway. Western blot analysis and immunolocalization revealed that the cells did not express iNOS, eNOS was expressed only in blood vessels and capillaries whereas nNOS was expressed at high levels next to the plasma membrane of all cells. Accordingly, the nNOS inhibitor 7-nitroindazole (7-NI) inhibited BS- but not CCKJ-evoked [Ca2+]i oscillations and Ca2+ influx into SMG acinar and duct cells. Thus, together, our findings favor nNOS as the isoform activated by the Ca2+ released from internal stores to generate cGMP and regulate Ca2+ influx.
越来越多的细胞类型中发现,一氧化氮合酶(NOS)途径通过生成环鸟苷酸(cGMP)来调节激动剂激活的钙离子内流。在本研究中,我们研究了NOS途径在激动剂诱发的细胞内钙离子浓度([Ca2+]i)振荡中的作用,并试图确定最有可能调节钙离子内流的NOS同工型。为此,我们首先表明,作用于胰腺腺泡细胞的两种钙离子动员激动剂,蛙皮素(BS)和胆囊收缩素类似物CCK-JMV-180(CCKJ),诱发不同类型的[Ca2+]i振荡。BS诱发的[Ca2+]i振荡迅速变得严重依赖细胞外钙离子的存在,而CCKJ诱发的振荡在没有钙离子内流的情况下会持续很长时间。这种差异行为使我们能够分离钙离子内流并研究其调节,同时控制对参与产生[Ca2+]i振荡的所有其他钙离子转运事件的非特异性影响。NOS途径中选择性步骤的抑制剂抑制激动剂诱导的cGMP产生。然后使用这些抑制剂表明,用还原血红蛋白清除一氧化氮(NO)、用1H-[1,2,4]恶二唑并[4,3-a]喹喔啉-1-酮(ODQ)抑制鸟苷酸环化酶以及用Rp-8-pCPT-cGMPS抑制蛋白激酶G可抑制BS诱发的[Ca2+]i振荡,但不抑制CCKJ诱发的振荡。这些发现扩展到了颌下腺的导管和腺泡细胞。在这些细胞中,钙离子动员激动剂刺激大量钙离子内流,这被NOS途径的所有抑制剂所抑制。蛋白质印迹分析和免疫定位显示,这些细胞不表达诱导型NOS(iNOS),内皮型NOS(eNOS)仅在血管和毛细血管中表达,而神经元型NOS(nNOS)在所有细胞的质膜旁高水平表达。因此,nNOS抑制剂7-硝基吲唑(7-NI)抑制BS诱发但不抑制CCKJ诱发的[Ca2+]i振荡以及钙离子流入颌下腺腺泡和导管细胞。因此,我们的研究结果共同表明,nNOS是由细胞内储存释放的钙离子激活以生成cGMP并调节钙离子内流的同工型。